CacheBy
Thermo Fisher Scientific Pembrolizumab Recombinant Rabbit Monoclonal Antibody (94B9), MonoRab
원본

Thermo Fisher Scientific Pembrolizumab Recombinant Rabbit Monoclonal Antibody (94B9), MonoRab

상품 한눈에 보기

사람 PD-1 단백질을 인식하는 재조합 토끼 단클론 항체로, Pembrolizumab을 면역원으로 제작되었습니다. ELISA 및 Blocking Assay에 적합하며, 단백질 A로 정제된 동결건조 형태입니다. 연구용으로만 사용 가능합니다.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ADRepligen 웨비나PATsmart를 활용한 바이오공정 분석 전략 · 10/7 오전 10시자세히보기
Thermo Fisher Scientific A0200840 Pembrolizumab Recombinant Rabbit Monoclonal Antibody (94B9), MonoRab 40 ug pk판매 단위 pk
재고 확인 필요
339,200원VAT 포함 373,120원

Thermo Fisher Scientific · Thermo Fisher Scientific Pembrolizumab Recombinant Rabbit Monoclonal Antibody (94B9), MonoRab

Applications and Tested Dilution

Application Tested Dilution
ELISA (ELISA) 0.01–0.1 µg/mL
Blocking Assay (BLOCK) 10–50 µg/mL

Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Rabbit / IgG
Expression System Mammalian cells
Class Recombinant Monoclonal
Type Antibody
Clone 94B9
Immunogen Pembrolizumab
Conjugate Unconjugated
Form Lyophilized
Purification Protein A
Storage Buffer PBS, pH 7.4
Contains 0.02% sodium azide
Storage Conditions -20°C or -80°C if preferred
Shipping Conditions Ambient (domestic); Wet ice (international)

Product Specific Information

Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.

Pembrolizumab (Keytruda) is a humanized monoclonal antibody approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in activation of T-cell-mediated immune responses against tumor cells.

GenScript MonoRab™ Anti-Pembrolizumab Antibody (94B9), mAb, Rabbit is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a rabbit immunized with Pembrolizumab.

Target Information

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that binds to PD-1 and inhibits its interaction with PD-L1, leading to T-cell activation against tumor cells. It is approved for the treatment of unresectable or metastatic melanoma.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.